Express Investigation: How a life saving cancer drug is counterfeited

About this episode

This episode discusses an investigation into the counterfeit market for a leading cancer drug in India and its implications for patient access.

While advances in early detection and treatment have reduced cancer deaths in many parts of the world, that progress hasn’t reached everyone. In India, cancer cases are rising, with nearly 14 lakh diagnoses in 2022—and access to life-saving drugs remains a major challenge. An investigation by The Indian Express, in collaboration with the International Consortium of Investigative Journalists, reveals how one of the world’s leading cancer drugs, Keytruda, remains out of reach for many patients. It also uncovers how gaps in regulation have allowed counterfeit versions of the drug to enter the market. Drawing on over 12,000 documents and records of more than 150 patients, the investigation lays bare the scale of the problem—and its human cost. In this episode, we speak with The Indian Express' Kaunain Sheriff and Anonna Dutt, who led this investigation. Hosted and produced by Shashank Bhargava Edited and mixed by Suresh Pawar

People in this episode

Hosts: Shashank Bhargava, Suresh Pawar

Guests: Kaunain Sheriff, Anonna Dutt

Topics covered

• cancer treatment
• counterfeit drugs
• healthcare access
• investigative journalism

Keywords

• Keytruda
• cancer
• India
• regulation
• healthcare

Mentioned in this episode

Products: Keytruda

Places: India

More episodes of 3 Things

• The Catch Up: Delhi Gymkhana files, and more (12 June) · June 12, 2026 · 4 min
• Indian sailors killed in Hormuz, relief for airlines, and risks of a wider war · June 12, 2026 · 23 min
• The Catch Up: 3 Indian sailors killed in US attack (11 June) · June 11, 2026 · 6 min
• Mobile Creches: Accelerating action on Early Childhood Development · June 11, 2026 · 18 min
• Khan sir controversy, a road not built, and Modi becomes longest serving PM · June 11, 2026 · 26 min
• The Catch Up: Khan Sir knocks on Patna High Court’s doors for relief (11 June) · June 10, 2026 · 5 min